Clinical Trial
TMS for Exposure Therapy Resistant OCD (TETRO)
ClinicalTrials.gov5/16/2022·05/16/22🌐 Europe
Summary
This Phase 3 multicenter randomized controlled trial evaluates repetitive transcranial magnetic stimulation for exposure therapy-resistant obsessive-compulsive disorder. The TETRO study delivers low-frequency rTMS to the pre-supplementary motor area combined with exposure response prevention therapy in 250 adults across Dutch centers.
Why it matters
As the largest TMS trial for OCD to date, TETRO is positioned to definitively establish rTMS as an insured treatment for resistant OCD. If cost-effectiveness is demonstrated, this could lead to immediate healthcare coverage changes and broad clinical adoption across Europe.
#Phase 3#OCD#Neurostimulation#TMS#Non-invasive#Mental Health Tech#Europe
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in